Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index; 28 of the 63 sources its claims cite were checked for support.
Abstract
Significance: The main advance of this study is the development of a microengineered model of human intestinal inflammation and bacterial overgrowth that permits analysis of individual contributors to the pathophysiology of intestinal diseases, such as ileus and inflammatory bowel disease, over a period of weeks in vitro. By studying living human intestinal epithelium, with or without vascular and lymphatic endothelium, immune cells, and mechanical deformation, as well as living microbiome and pathogenic microbes, we identified previously unknown contributions of specific cytokines, mechanical motions, and microbiome to intestinal inflammation, bacterial overgrowth, and control of barrier function. We provide proof-of-principle to show that the microfluidic gut-on-a-chip device can be used to create human intestinal disease models and gain new insights into gut pathophysiology.
Overview
CoChat Summary
TL;DR
A human gut-on-a-chip was used to coculture intestinal epithelial cells with commensal microbes, immune cells, and peristalsis-like mechanical deformation for over a week. The model showed that immune cells plus LPS or nonpathogenic *E. coli* drive a four-cytokine injury response, and that loss of mechanical deformation alone triggers bacterial overgrowth.
Key findings
- Caco-2 cells on-chip formed villi and had a transcriptome distinct from static Transwell cultures across 22,097 genes (P < 0.00001); coculture with VSL#3 probiotics shifted them closer to normal human ileum (P < 0.00001).
- LPS (15 μg/mL) or GFP-*E. coli* alone did not disrupt barrier function or induce cytokines, but with PBMCs they caused significant barrier loss and villus destruction; EIEC alone destroyed barrier and villus architecture within 24–36 h, and PBMCs accelerated/exacerbated injury.
- IL-1β, IL-6, IL-8, and TNF-α together were necessary and sufficient to induce villus injury; anti-IL-8 monoclonal antibody completely prevented injury, while IL-8 alone was not sufficient.
- Removing cyclic mechanical deformation while maintaining luminal flow more than doubled GFP-*E. coli* density within 21 h versus stretched chips (P < 0.001); VSL#3 increased TEER by >50% (P < 0.001), reduced EIEC injury (P < 0.01), and delayed injury onset by ~18 h.
Methods
- PDMS gut-on-a-chip with upper/lower microchannels separated by a porous ECM-coated membrane; Caco-2BBE intestinal epithelial cells were cultured under flow (30 μL/h; 0.02 dyne/cm²) and cyclic deformation (10% strain, 0.15 Hz), forming villi after ~100 h.
- Coculture experiments used VSL#3 probiotics, GFP-*E. coli*, enteroinvasive *E. coli* (EIEC), LPS (15 μg/mL), human PBMCs, and endothelial cells; antibiotics tested were 100 units/mL penicillin plus 100 μg/mL streptomycin.
- Analyses included TEER, phase/confocal microscopy, cytokine measurements, qPCR, and Affymetrix Human Genome 1.0 ST microarrays compared with GEO normal small intestine data; statistics used one-way ANOVA with Tukey-Kramer, P < 0.05, and mean ± SEM.
Limitations
- Stated in the paper: Caco-2 cells originated from a human colorectal tumor; VSL#3 is not fully representative of the complex normal gut microbiome; the antibiotics used differ from those most common in the clinic; PBMCs are a mixed immune population and do not include all gut immune components; species-level population dynamics were not analyzed.
- Evident from the text: this is an in vitro synthetic microdevice, not human or animal in vivo, so findings require validation in more complex systems; the model uses a minimal set of cell types and microbial strains, and the authors note it could be improved with primary/iPS-derived epithelium, connective tissue, immune subsets, and more complex patient-derived microbial communities.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
17 Valid · 3 Not valid · 19 Not checked · 88 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Suppression of peristalsis also has been strongly associated with intestinal pathology, inflammation (4,5), and small intestinal bacterial overgrowth (5,6) in patients with Crohn's disease (7) and ileus (8).”
§ Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip > microbiome | gut-on-a-chip | intestine | inflammatory bowel disease | mechanical
What the sources say
- Partly supportedcites [4] matched to “The effects of mechanical forces on intestinal physiology and pathology” (2009) sourceExperimental — accuracy not yet measured
In “Effects of Altered Physical Forces” (page unavailable), the review says that in ileus the mucosa becomes atrophic and peristaltic contractions may be absent, which could contribute to pathology. That supports the ileus portion to which this citation is attached, but the passage does not establish the claimed strong association; it presents the contribution to pathology as possible. The sentence assigns bacterial overgrowth to other citations. (LLM, conf=0.84)
- Partly supportedcites [5] matched to “Mechanism of abnormal intestinal motility in inflammatory bowel disease: How smooth muscle contraction is reduced?” (2007) sourceExperimental — accuracy not yet measured
The paper’s “Other mechanisms” section links intestinal inflammation and tissue abnormalities with impaired motility and reduced smooth-muscle contractility. The body passages do not establish an association with small intestinal bacterial overgrowth or the full claim specifically in patients with Crohn’s disease and ileus. Page numbers are unavailable in our copy. (LLM, conf=0.82)
- Not checked — no full text of the sourcecites [6] matched to “Small Intestinal Bacterial Overgrowth: A Framework for Understanding Irritable Bowel Syndrome” (2004) source
- Supportedcites [7] matched to “Small intestinal bacterial overgrowth syndrome” (2010) source
This source is cited for the association between suppressed peristalsis and small intestinal bacterial overgrowth, not for the separate Crohn’s disease and ileus examples. In the Pathogenesis section (page not available), it says antegrade peristalsis prevents bacterial attachment and that SIBO can develop when this defence is disrupted; the Abstract also identifies motility disorders among causes of SIBO. (LLM, conf=0.87)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“the maximum specific growth rates of Lactobacillus spp.(53), Bifidobacterium spp.(54), and Streptococcus sp.(55) are similar under high-nutrient conditions.”
§ Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip > Discussion
What the sources say
- Not checked — no full text of the sourcecites [53] matched to “Growth and lactic acid production in batch culture of Lactobacillus rhamnosus in a defined medium” (1999) source
- Not checked — no full text of the sourcecites [54] matched to “Specific growth rate of bifidobacteria cultured on different sugars” (2002) source
- Could not verifycites [55] matched to “Growth and exopolysaccharide production by Streptococcus thermophilus ST1 in skim milk” (2011) sourceExperimental — accuracy not yet measured
The Growth experiments section describes Streptococcus thermophilus ST1 cultured in skim milk with nutrient supplements, and Table 1 reports cell counts after 32 hours. Our copy does not report a maximum specific growth rate or compare it with rates for Lactobacillus and Bifidobacterium (searched: specific growth rate, maximum growth rate, and the three genera). Page numbers were not available in our copy. (LLM, conf=0.75)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“they were only able to perform the coculture for a short period (4-48 h).”
§ Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip > Discussion
What the sources say
- Partly supportedcites [56] matched to “In Vitro Prevention of Salmonella Lipopolysaccharide-Induced Damages in Epithelial Barrier Function by Various Lactobacillus Strains” (2013) sourceExperimental — accuracy not yet measured
Materials and Methods §2.3 reports Lactobacillus exposure for 1, 6, and 24 hours, supporting that this study used short periods. The paper does not establish a 4–48-hour range for past studies or say that they were only able to coculture for that long. No page number is available in our copy. (LLM, conf=0.79)
- Not checked — no full text of the sourcecites [57] matched to “Inhibitory effects of Lactobacillus casei subsp. rhamnosus on Salmonella lipopolysaccharide-induced inflammation and epithelial barrier dysfunction in a co-culture model using Caco-2/peripheral blood mononuclear cells” (2010) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“we discovered that the loss of physiological mechanical deformation is itself sufficient to induce small intestinal bacterial overgrowth similar to that observed in some patients with ileus (8) as well as IBD (6,7).”
§ Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip > Discussion
What the sources say
- Not checked — no full text of the sourcecites [8] matched to “Systemic consequences of ileus” (2003) source
- Not checked — no full text of the sourcecites [6] matched to “Small Intestinal Bacterial Overgrowth: A Framework for Understanding Irritable Bowel Syndrome” (2004) source
- Supportedcites [7] matched to “Small intestinal bacterial overgrowth syndrome” (2010) source
Citation (8) is attached to the comparison with patients with ileus, not to the citing authors’ own discovery about mechanical deformation. The source’s “Small intestinal obstruction and stagnation” section reports that small intestinal pseudo-obstruction can be complicated by SIBO, supporting that comparison. The indexed passage has no page number. (LLM, conf=0.86)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By ceasing peristalsis-like motions while maintaining luminal flow, lack of epithelial deformation was shown to trigger bacterial overgrowth similar to that observed in patients with ileus and inflammatory bowel disease.”
§ Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip > Abstract
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
67 more claims
Create a free account to see all 127 claims and every source verdict.
- Probably not a substantial claim. 22
- It may state two separate claims as one. 42
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Addition of lipopolysaccharide endotoxin to the luminal microchannel also was shown to induce secretion of the proinflammatory cytokines, interleukin-1β, -6, -8, and tumor necrosis factor-α into the lower vascular channel.”
From Microfluidic Organ-on-a-Chip Models of Human Intestine (2018) · cites this paper as [42]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, these studies were carried out in the absence of mechanical deformations similar to those associated with peristalsis that can critically influence the microbial growth in the intestine.42”
From Microfluidic Organ-on-a-Chip Models of Human Intestine (2018) · cites this paper as [42]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A more sophisticated, microfluidic 2-channel Gut Chip model has been developed that enables human intestinal epithelium, capillary endothelium, immune cells, and even commensal microbial cells to grow, coexist, and interact while experiencing physiologically relevant fluid flow and peristalsis-like mechanical deformations in vitro.42”
From Microfluidic Organ-on-a-Chip Models of Human Intestine (2018) · cites this paper as [42]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although static Transwell cultures offer better access to the apical lumen of these organoids, they still lack other organ-level features of the intestine, including an endothelium-lined vascular compartment, flow, cyclic mechanical deformation, or immune cells, which have been shown to be important for mimicking intestinal physiology and pathophysiology in the human Gut Chip.42”
From Microfluidic Organ-on-a-Chip Models of Human Intestine (2018) · cites this paper as [42]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, additional studies revealed that cessation of cyclic peristalsis-like mechanical motions caused an increase in bacterial overgrowth in the Gut Chip, which closely resembled the small intestinal bacterial overgrowth that can result from cessation of peristalsis in patients with ileus.”
From Microfluidic Organ-on-a-Chip Models of Human Intestine (2018) · cites this paper as [42]
Experimental — accuracy not yet measured
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029
Summaries of Affymetrix GeneChip probe level data
Irizarry, R. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng015 · Cited by 4,887
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
The gut microbiota--masters of host development and physiology
Sommer, F., & Bäckhed, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2974 · Cited by 3,681
TNF-mediated inflammatory disease
Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806
Kim, H. J., Huh, D., Hamilton, G., & Ingber, D. E. (2012) · Lab on a Chip · doi:10.1039/c2lc40074j · Cited by 1,734
Self-citationReciprocal interactions of the intestinal microbiota and immune system
Maynard, C. L., Elson, C. O., Hatton, R. D., & Weaver, C. T. (2012) · Nature · doi:10.1038/nature11551 · Cited by 1,598
Engineering cell shape and function
Singhvi, R., Kumar, A., Lopez, G. P., Stephanopoulos, G. N., Wang, D. I. C., Whitesides, G. M., & Ingber, D. E. (1994) · Science · doi:10.1126/science.8171320 · Cited by 1,453
Self-citationGrowing Self-Organizing Mini-Guts from a Single Intestinal Stem Cell: Mechanism and Applications
Sato, T., & Clevers, H. (2013) · Science · doi:10.1126/science.1234852 · Cited by 1,170
Sartor, R. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.024 · Cited by 1,052
Vantrappen, G., Janssens, J., Hellemans, J., & Ghoos, Y. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108740 · Cited by 815
Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery.
Rutgeerts, P., Geboes, K., Vantrappen, G., Kerremans, R., Coenegrachts, J. L., & Coremans, G. (1984) · Gut · doi:10.1136/gut.25.6.665 · Cited by 787
Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation
Kim, H. J., & Ingber, D. E. (2013) · Integrative Biology · doi:10.1039/c3ib40126j · Cited by 750
Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease
Sharon, P., & Stenson, W. F. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80015-3 · Cited by 738
Martin, H. M., Campbell, B. J., Hart, C. A., Mpofu, C., Nayar, M., Singh, R., Englyst, H., Williams, H. F., & Rhodes, J. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.054 · Cited by 716
Microfabrication of human organs-on-chips
Huh, D., Kim, H. J., Fraser, J. P., Shea, D. E., Khan, M., Bahinski, A., Hamilton, G. A., & Ingber, D. E. (2013) · Nature Protocols · doi:10.1038/nprot.2013.137 · Cited by 712
Self-citationRole of cytokines in inflammatory bowel disease
Sanchez-Muñoz, F., Dominguez-Lopez, A., & Yamamoto-Furusho, J. K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4280 · Cited by 699
Resta-Lenert, S., & Barrett, K. E. (2003) · Gut · doi:10.1136/gut.52.7.988 · Cited by 642
Small intestinal bacterial overgrowth syndrome
Bures, J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i24.2978 · Cited by 620
Antibiotic therapy in inflammatory bowel disease: A systematic review and meta-analysis
Khan, K. J., Ullman, T. A., Ford, A. C., Abreu, M. T., Abadir, A., Marshall, J. K., Talley, N. J., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.72 · Cited by 569
Cytokines in Inflammatory Bowel Disease
Rogler, G., & Andus, T. (1998) · World Journal of Surgery · doi:10.1007/s002689900401 · Cited by 484
Haller, D., Bode, C., Hammes, W. P., Pfeifer, A. M. A., Schiffrin, E. J., & Blum, S. (2000) · Gut · doi:10.1136/gut.47.1.79 · Cited by 466
Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease
Singer, I. I., Kawka, D. W., Schloemann, S., Tessner, T., Riehl, T., & Stenson, W. F. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70196-9 · Cited by 455
Targeting melanocortin receptors as a novel strategy to control inflammation
Catania, A., Gatti, S., Colombo, G., & Lipton, J. M. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.1.1 · Cited by 438
Salminen, S., Isolauri, E., & Salminen, E. (1996) · Antonie van Leeuwenhoek · doi:10.1007/bf00395941 · Cited by 406
Small Intestinal Bacterial Overgrowth: A Framework for Understanding Irritable Bowel Syndrome
Lin, H. C. (2004) · JAMA · doi:10.1001/jama.292.7.852 · Cited by 396
Tsilingiri, K., Barbosa, T., Penna, G., Caprioli, F., Sonzogni, A., Viale, G., & Rescigno, M. (2012) · Gut · doi:10.1136/gutjnl-2011-300971 · Cited by 364
Salminen, S., Isolauri, E., & Salminen, E. (1996) · Lactic Acid Bacteria: Genetics, Metabolism and Applications · doi:10.1007/978-94-009-1774-3_15 · Cited by 348
A Systematic Review of Diagnostic Tests for Small Intestinal Bacterial Overgrowth
Khoshini, R., Dai, S.-C., Lezcano, S., & Pimentel, M. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0065-1 · Cited by 323
Regulation of the immune response and inflammation by histamine and histamine receptors
O’Mahony, L., Akdis, M., & Akdis, C. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.06.051 · Cited by 313
Reimund, J. M., Wittersheim, C., Dumont, S., Muller, C. D., Baumann, R., Poindron, P., & Duclos, B. (1996) · Journal of Clinical Immunology · doi:10.1007/bf01540912 · Cited by 281
Jonkers, D., Penders, J., Masclee, A., & Pierik, M. (2012) · Drugs · doi:10.2165/11632710-000000000-00000 · Cited by 240
The role of the sympathetic nervous system in intestinal inflammation
Straub, R. H., Wiest, R., Strauch, U. G., Härle, P., & Schölmerich, J. (2006) · Gut · doi:10.1136/gut.2006.091322 · Cited by 237
Van De Walle, J., Hendrickx, A., Romier, B., Larondelle, Y., & Schneider, Y.-J. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.04.002 · Cited by 212
The effects of mechanical forces on intestinal physiology and pathology
Gayer, C. P., & Basson, M. D. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.02.011 · Cited by 195
Caco-2 cells express a combination of colonocyte and enterocyte phenotypes
Engle, M. J., Goetz, G. S., & Alpers, D. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199803)174:3<362::aid-jcp10>3.0.co;2-b · Cited by 182
Gene Expression Dynamics Inspector (GEDI): for integrative analysis of expression profiles
Eichler, G. S., Huang, S., & Ingber, D. E. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg307 · Cited by 180
Self-citationChemotactic activity in inflammatory bowel disease: Role of leukotriene B4
Lobos, E. A., Sharon, P., & Stenson, W. F. (1987) · Digestive Diseases and Sciences · doi:10.1007/bf01296664 · Cited by 143
Chelvarajan, R. L., Collins, S. M., Van Willigen, J. M., & Bondada, S. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0804449 · Cited by 141
Annexin A1 regulates intestinal mucosal injury, inflammation, and repair
Babbin, B. A., Laukoetter, M. G., Nava, P., Koch, S., Lee, W. Y., Capaldo, C. T., Peatman, E., Severson, E. A., Flower, R. J., Perretti, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.5035 · Cited by 134
Chart, H., Smith, H. R., Ragione, R. M. L., & Woodward, M. J. (2000) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2000.01211.x · Cited by 129
Systemic consequences of ileus
Madl, C., & Druml, W. (2003) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/s1521-6918(03)00022-2 · Cited by 124
Parlesak, A., Haller, D., Brinz, S., Baeuerlein, A., & Bode, C. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01495.x · Cited by 109
Li, M., Edamatsu, H., Kitazawa, R., Kitazawa, S., & Kataoka, T. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp125 · Cited by 104
Ohama, T., Hori, M., & Ozaki, H. (2007) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.43.43 · Cited by 103
Im, E., Riegler, F. M., Pothoulakis, C., & Rhee, S. H. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00120.2012 · Cited by 79
Growth and lactic acid production in batch culture of Lactobacillus rhamnosus in a defined medium
Berry, A. R., Franco, C. M. M., Zhang, W., & Middelberg, A. P. J. (1999) · Biotechnology Letters · doi:10.1023/a:1005483609065 · Cited by 75
Paradigms for Mechanical Signal Transduction in the Intestinal Epithelium
Basson, M. D. (2003) · Digestion · doi:10.1159/000076385 · Cited by 73
Macrophage activation, chronic inflammation and gastrointestinal disease
Tanner, A. R., Arthur, M. J., & Wright, R. (1984) · Gut · doi:10.1136/gut.25.7.760 · Cited by 70
Gionchetti, P., Campieri, M., Belluzzi, A., Bertinelli, E., Ferretti, M., Brignola, C., Poggioli, G., Miglioli, M., & Barbara, L. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02088059 · Cited by 70
李, 明. (2009) · Kobe University Repository Kernel (Kobe University) · Cited by 70
Erratum: The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature reviews. Immunology · doi:10.1038/nri2614 · Cited by 66
Fang, H.-W., Fang, S.-B., Chiang Chiau, J.-S., Yeung, C.-Y., Chan, W.-T., Jiang, C.-B., Cheng, M.-L., & Lee, H.-C. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.009662-0 · Cited by 62
Janelsins, B. M., Lu, M., & Datta, S. K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311987111 · Cited by 56
Haller, D., Holt, L., Parlesak, A., Zanga, J., Bäuerlein, A., Sartor, R. B., & Jobin, C. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01874.x · Cited by 54
Growth and exopolysaccharide production by Streptococcus thermophilus ST1 in skim milk
Zhang, T., Zhang, C., Li, S., Zhang, Y., & Yang, Z. (2011) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822011000400033 · Cited by 53
Yeung, C.-Y., Chiang Chiau, J.-S., Chan, W.-T., Jiang, C.-B., Cheng, M.-L., Liu, H.-L., & Lee, H.-C. (2013) · Gastroenterology Research and Practice · doi:10.1155/2013/973209 · Cited by 49
Spotlight on VSL#3 Probiotic Mixture in Chronic Inflammatory Bowel Diseases1
Chapman, T. M., Plosker, G. L., & Figgitt, D. P. (2007) · BioDrugs · doi:10.2165/00063030-200721010-00007 · Cited by 48
The use of scanning electron microscopy in the study of the intestinal villi
Toner, P. G., & Carr, K. E. (1969) · The Journal of Pathology · doi:10.1002/path.1710970405 · Cited by 47
Federico, A., Tuccillo, C., Grossi, E., Abbiati, R. A., Garbagna, N., Romano, M., Tiso, A., Blanco, C. D. V., & Loguercio, C. (2009) · PubMed · Cited by 34
Specific growth rate of bifidobacteria cultured on different sugars
Rada, V., Bartoňová, J., & Vlková, E. (2002) · Folia Microbiologica · doi:10.1007/bf02818784 · Cited by 30
Growth and exopolysaccharide production by Streptococcus thermophilus ST1 in skim milk
Zhang, T.-H., Zhang, C.-H., Li, S.-Y., Zhang, Y.-C., & Yang, Z.-N. (2011) · Brazilian Journal of Microbiology · doi:10.1590/s1517-838220110004000033 · Cited by 30
Janelsins, B., & Datta, S. K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.192.supp.133.1
Corrigendum: Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Khan, K. J., Ullman, T. A., Ford, A. C., Abreu, M. T., Abadir, A., Marshall, J. K., Talley, N. J., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.131
Cited by
Is it time to start transitioning from 2D to 3D cell culture?
Jensen, C., & Teng, Y. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00033 · Cited by 1,640
Human organs-on-chips for disease modelling, drug development and personalized medicine
Ingber, D. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00466-9 · Cited by 1,589
Self-citationAdvances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017
Modelling cancer in microfluidic human organs-on-chips
Sontheimer-Phelps, A., Hassell, B. A., & Ingber, D. E. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0104-6 · Cited by 906
Self-citationA complex human gut microbiome cultured in an anaerobic intestine-on-a-chip
Jalili-Firoozinezhad, S., Gazzaniga, F. S., Calamari, E. L., Camacho, D. M., Fadel, C. W., Bein, A., Swenor, B., Nestor, B., Cronce, M. J., Tovaglieri, A., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0397-0 · Cited by 855
Self-citation
Metadata
- Authors
- Kim, H. J., Li, H., Collins, J. J., & Ingber, D. E.
- Affiliations
- Harvard University (US)
- Broad Institute (US)
- Boston Children's Hospital (US)
- Corresponding author
- Ingber, Donald E.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2015-12-14
- Volume
- 113
- Issue
- 1
- Pages
- E7-15
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4711860
- OpenAlex
- W2214747519
- Cited by
- 922
- References
- 64
- Citations by year
- 2026: 32 · 2025: 67 · 2024: 101 · 2023: 90 · 2022: 98 · 2021: 146 · 2020: 117 · 2019: 78 · 2018: 88 · 2017: 73 · 2016: 31
- FWCI
- 22.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Funders
- Harvard University
- Hamilton Health Sciences Foundation
- U.S. Food and Drug Administration (HHSF223201310079C)
- Defense Advanced Research Projects Agency (W911NF-12-2-0036)
- Advanced Research Projects Agency
- Hansjörg Wyss Institute for Biologically Inspired Engineering, Harvard University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- gut-on-a-chip, intestinal bacterial overgrowth, intestinal inflammation, gut microbiota, mechanical deformation, peristalsis, intestinal epithelial cells, intestinal barrier function, inflammatory cytokines, lipopolysaccharide, inflammatory bowel disease, ileus, probiotics, antibiotics, commensal microorganisms, co-culture model
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteria, Humans, Intestinal Mucosa, Models, Biological, Peristalsis, Tumor Necrosis Factor-alpha, Inflammatory Bowel Diseases, Interleukin-6, Interleukin-8, Caco-2 Cells, Probiotics, Ileus, Interleukin-1beta, Lab-On-A-Chip Devices, Microbiota, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.